A detailed history of Quest Partners LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 530 shares of ATRC stock, worth $16,281. This represents 0.0% of its overall portfolio holdings.

Number of Shares
530
Previous 5,868 90.97%
Holding current value
$16,281
Previous $134 Million 88.88%
% of portfolio
0.0%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$20.34 - $29.5 $108,574 - $157,471
-5,338 Reduced 90.97%
530 $14.9 Million
Q2 2024

Aug 06, 2024

BUY
$19.86 - $29.09 $32,292 - $47,300
1,626 Added 38.33%
5,868 $134 Million
Q1 2024

May 09, 2024

BUY
$28.21 - $37.78 $38,027 - $50,927
1,348 Added 46.58%
4,242 $129 Million
Q4 2023

Feb 09, 2024

BUY
$32.99 - $43.25 $95,473 - $125,165
2,894 New
2,894 $103 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.43B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.